Overview

Companies

Metrics

Purchase

Oncology Brand Commercialization: Resource Allocation divides averaged brand data into 28 divisions.  By picking the data divisions that are most relevant to you, you can build customized oncology data sets to address any number of real or hypothetical marketing situations.

For each data set, the report details resource levels for 6 time periods and 5 spending categories. 

TIME PERIODS

• Pre-clinical
• Phase I
• Phase II
• Phase III
• Launch
• 12-18 months post-launch

 

SPENDING CATEGORIES

• Brand total
• Brand activities
• Market research
• Thought leader development
• Advertising

 

BRAND DIVISIONS

Chapter 1: Drug Class

• Cytotoxics
• Innovative therapies

Chapter 2: Market Entrance 

• First-to-market brands
• Follow-on/me-too brands

Chapter 3: Indications

• Leukemia
• Breast cancer
• Lung cancer
• Prostate cancer
• Colorectal cancer

Chapter 4: Peak Sales

• Brands with projected peak annual sales of more than $1 billion
• Brands with projected peak annual sales of $500 million to $999 million
• Brands with projected peak annual sales of less than $500 million

Chapter 5: Line of Treatment

• First-line therapeutics
• Second-line therapeutics
• Third-line therapeutics

Chapter 6: Clinical Profile

• Brands with favorable clinical profiles
• Brands with average clinical profiles
• Brands with unfavorable clinical profiles

Chapter 7: Industry Sector

• Brands commercially supported by major pharmaceuticals companies
• Brands commercially supported by biotechnology companies

Chapter 8: Competitive Landscape

• Brands with strong competitive positions
• Brands with average competitive positions
• Brands with weak competitive positions

Chapter 9: Promotional Infrastructure

• Brands with access to strong internal resources
• Brands with access to average internal resources
• Brands with access to weak internal resources

Chapter 10: Drug Delivery

• Brands delivered orally
• Brands delivered intravenously